Screening Marine Microbial Metabolites as Promising Inhibitors of <i>Borrelia garinii</i>: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment

<div>(a) RMSD plot of control compound complexed with ADI. (b) RMSD plot of ADI complexed with CMNPD18759.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Screening Marine Microbial Metabolites as Promising Inhibitors of <i>Borrelia garinii</i>: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment 

Figure 6 | Screening Marine Microbial Metabolites as Promising Inhibitors of Borrelia garinii: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment 